What is Avita Shares Owned By Insiders? (NASDAQ:RCEL) - Macroaxis

Avita Medical Stock Shares Owned By Insiders

RCEL Stock  USD 12.21  0.60  4.68%   
Avita Medical fundamentals help investors to digest information that contributes to Avita Medical's financial success or failures. It also enables traders to predict the movement of Avita Stock. The fundamental analysis module provides a way to measure Avita Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avita Medical stock.
Total Stockholder EquityTotal Current Liabilities
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Avita Medical Company Shares Owned By Insiders Analysis

Avita Medical's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current Avita Medical Shares Owned By Insiders

    
  0.96 %  
Most of Avita Medical's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avita Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Avita Shares Owned By Insiders Driver Correlations

Understanding the fundamental principles of building solid financial models for Avita Medical is extremely important. It helps to project a fair market value of Avita Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Avita Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Avita Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Avita Medical's interrelated accounts and indicators.
0.83-0.29-0.970.870.640.99-0.910.810.850.710.960.090.410.70.480.80.79-0.85
0.83-0.59-0.810.570.410.78-0.650.850.820.60.90.230.270.50.390.850.83-0.88
-0.29-0.590.190.130.27-0.280.27-0.47-0.560.28-0.340.08-0.19-0.09-0.45-0.45-0.440.37
-0.97-0.810.19-0.84-0.62-0.960.84-0.73-0.76-0.78-0.93-0.08-0.31-0.61-0.35-0.73-0.710.79
0.870.570.13-0.840.90.86-0.80.70.70.820.840.290.320.70.320.670.67-0.76
0.640.410.27-0.620.90.6-0.530.670.480.80.640.560.120.570.110.610.62-0.73
0.990.78-0.28-0.960.860.6-0.930.760.840.650.920.030.450.70.510.750.74-0.8
-0.91-0.650.270.84-0.8-0.53-0.93-0.73-0.75-0.52-0.820.04-0.62-0.82-0.63-0.71-0.710.74
0.810.85-0.47-0.730.70.670.76-0.730.820.570.850.370.310.630.410.950.95-0.99
0.850.82-0.56-0.760.70.480.84-0.750.820.440.910.110.290.510.50.80.79-0.81
0.710.60.28-0.780.820.80.65-0.520.570.440.740.410.140.530.040.590.57-0.7
0.960.9-0.34-0.930.840.640.92-0.820.850.910.740.20.350.650.450.860.84-0.9
0.090.230.08-0.080.290.560.030.040.370.110.410.2-0.220.12-0.180.320.32-0.39
0.410.27-0.19-0.310.320.120.45-0.620.310.290.140.35-0.220.850.910.350.35-0.3
0.70.5-0.09-0.610.70.570.7-0.820.630.510.530.650.120.850.80.60.6-0.65
0.480.39-0.45-0.350.320.110.51-0.630.410.50.040.45-0.180.910.80.380.39-0.37
0.80.85-0.45-0.730.670.610.75-0.710.950.80.590.860.320.350.60.381.0-0.95
0.790.83-0.44-0.710.670.620.74-0.710.950.790.570.840.320.350.60.391.0-0.95
-0.85-0.880.370.79-0.76-0.73-0.80.74-0.99-0.81-0.7-0.9-0.39-0.3-0.65-0.37-0.95-0.95
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 0.96% of Avita Medical are shares owned by insiders. This is 93.68% lower than that of the Biotechnology sector and 93.83% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 90.49% higher than that of the company.

Avita Shares Owned By Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avita Medical's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avita Medical could also be used in its relative valuation, which is a method of valuing Avita Medical by comparing valuation metrics of similar companies.
0.9637.9037.0525.40100%
Avita Medical is currently under evaluation in shares owned by insiders category among its peers.

Avita Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Avita Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Avita Medical's managers, analysts, and investors.
46.7%
Environmental
Governance
Social

Avita Fundamentals

Return On Equity-1.52
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-50%0%50%100%150%200%250%300%
Return On Asset-0.45
Profit Margin(0.95) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-100%-80%-60%-40%-20%0%
Operating Margin(0.71) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-100%-80%-60%-40%-20%0%20%
Current Valuation321.34 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-310%200%400%600%800%1,000%1,200%
Shares Outstanding26.22 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-3110,000%20,000%30,000%40,000%50,000%60,000%
Shares Owned By Insiders0.96 %
Shares Owned By Institutions23.49 %
Number Of Shares Shorted1.17 M
Price To Book26.18 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-50%0%50%
Price To Sales5.78 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-80%-60%-40%-20%
Revenue50.14 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312,000%4,000%6,000%8,000%
Gross Profit28.38 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-310%1,000%2,000%3,000%4,000%5,000%6,000%7,000%
EBITDA(57.92 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-315,000%10,000%15,000%20,000%25,000%
Net Income(35.38 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-315,000%10,000%15,000%
Cash And Equivalents84.17 M
Cash Per Share0.67 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-50%0%50%100%150%200%
Total Debt62.58 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-310%50,000%100,000%150,000%200,000%250,000%300,000%350,000%
Debt To Equity0.01 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31500%1,000%1,500%2,000%
Current Ratio9.64 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-50%0%50%100%
Book Value Per Share0.47 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-80%-60%-40%-20%0%
Cash Flow From Operations(38.01 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-50%0%50%100%
Short Ratio10.24 X
Earnings Per Share(2.13) X
Price To Earnings To Growth(0.04) X
Target Price16.48
Number Of Employees207
Beta1.54
Market Capitalization346.86 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-310%200%400%600%800%1,000%1,200%
Total Asset111.64 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-100%-50%0%50%
Retained Earnings(297.97 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-60%-40%-20%0%20%40%60%
Working Capital90.81 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-10%-5%0%5%10%15%
Net Asset111.64 M

About Avita Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Avita Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avita Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avita Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Avita Medical is a strong investment it is important to analyze Avita Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avita Medical's future performance. For an informed investment choice regarding Avita Stock, refer to the following important reports:
Check out Avita Medical Piotroski F Score and Avita Medical Altman Z Score analysis.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.13)
Revenue Per Share
2.335
Quarterly Revenue Growth
0.432
Return On Assets
(0.45)
Return On Equity
(1.52)
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.


 
News Freq…Investor S…